| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,116,490 | 4 | 100 |
Sells | $0 | 0 | 0 |
| PACE GARY W | director | 2 | $1.04M | 0 | $0 | $1.04M |
| Mohindru Mani | Chief Executive Officer | 2 | $79,890 | 0 | $0 | $79,890 |
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; …
Over the last 12 months, insiders at Cardiff Oncology, Inc. have bought $1.12M and sold $0 worth of Cardiff Oncology, Inc. stock.
On average, over the past 5 years, insiders at Cardiff Oncology, Inc. have bought $651,735 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: PACE GARY W (director) — $1.04M. Mohindru Mani (Chief Executive Officer) — $79,890.
The last purchase of 687,285 shares for transaction amount of $1,000,000 was made by PACE GARY W (director) on 2026‑07‑14.
| 2026-07-14 | PACE GARY W | director | 687,285 1.1165% | $1.46 | $1,000,000 | -24.89% | ||
| 2026-07-14 | Mohindru Mani | Chief Executive Officer | 34,364 0.0558% | $1.46 | $50,000 | -24.89% | ||
| 2026-06-18 | PACE GARY W | director | 30,000 0.0442% | $1.22 | $36,600 | -15.70% | ||
| 2026-06-18 | Mohindru Mani | Chief Executive Officer | 24,703 0.0361% | $1.21 | $29,891 | -15.70% | ||
| 2025-07-30 | PACE GARY W | director | 290,000 0.4289% | $2.45 | $710,500 | -21.29% | ||
| 2024-12-18 | Levine James E. | Chief Financial Officer | 2,400 0.0041% | $5.00 | $12,000 | -35.97% | ||
| 2024-12-17 | Levine James E. | Chief Financial Officer | 2,752 0.0053% | $5.42 | $14,905 | -46.17% | ||
| 2024-12-16 | Levine James E. | Chief Financial Officer | 2,564 0.0048% | $3.83 | $9,820 | -28.29% | ||
| 2024-12-12 | TANNENBAUM RENEE P | director | 10,000 0.0209% | $3.42 | $34,224 | -11.16% | ||
| 2024-12-11 | PACE GARY W | director | 361,615 0.5003% | $2.60 | $940,199 | -20.95% | ||
| 2023-12-19 | PACE GARY W | director | 30,000 0.0671% | $1.37 | $41,100 | +89.71% | ||
| 2022-11-25 | Erlander Mark | Chief Executive Officer | 10,000 0.0236% | $1.43 | $14,300 | +14.03% | ||
| 2022-09-19 | White Lale | director | 15,000 0.0327% | $1.64 | $24,525 | -7.51% | ||
| 2022-09-16 | Levine James E. | Chief Financial Officer | 30,000 0.0682% | $1.56 | $46,710 | +0.95% | ||
| 2022-09-16 | Armitage James O | director | 13,000 0.0296% | $1.56 | $20,233 | +0.95% | ||
| 2022-09-15 | PACE GARY W | director | 150,000 0.3544% | $1.71 | $256,500 | -4.79% | ||
| 2022-09-15 | TANNENBAUM RENEE P | director | 10,000 0.0237% | $1.72 | $17,168 | -4.79% | ||
| 2021-09-21 | PACE GARY W | director | 30,000 0.0764% | $6.75 | $202,500 | -58.36% | ||
| 2021-09-10 | Levine James E. | Chief Financial Officer | 30,000 0.0779% | $6.47 | $194,000 | -54.92% | ||
| 2021-03-26 | Markin Rodney S | director | 2,900 0.0081% | $10.32 | $29,933 | -37.55% |
| PACE GARY W | director | 2043661 2.627% | $1.76M | 12 | 0 | +59.69% |
| Mohindru Mani | Chief Executive Officer | 59067 0.0759% | $50,980.73 | 2 | 0 | |
| Hunter Robert Merrill | 10 percent owner | 5065004 6.5107% | $4.37M | 1 | 0 | |
| BRIDGER MANAGEMENT, LLC | 2968115 3.8153% | $2.56M | 7 | 0 | <0.0001% | |
| Sheinerman Kira | director | 909090 1.1686% | $784,635.58 | 1 | 0 | |
| CERRONE GABRIEL | director | 719526 0.9249% | $621,022.89 | 5 | 0 | |
| White Lale | director | 113788 0.1463% | $98,210.42 | 2 | 0 | +295.89% |
| Levine James E. | Chief Financial Officer | 67716 0.087% | $58,445.68 | 5 | 0 | <0.0001% |
| Tennant Stanley | director | 28839 0.0371% | $24,890.94 | 6 | 1 | <0.0001% |
| Erlander Mark | Chief Executive Officer | 24481 0.0315% | $21,129.55 | 4 | 0 | +129.42% |
| Markin Rodney S | director | 23879 0.0307% | $20,609.96 | 3 | 0 | +280.88% |
| JACOB GARY S | director | 21922 0.0282% | $18,920.88 | 2 | 0 | +280.78% |
| ZANIBONI STEVE | CFO | 21329 0.0274% | $18,409.06 | 2 | 0 | <0.0001% |
| SCHUH ANTONIUS | CEO | 20000 0.0257% | $17,262.00 | 1 | 0 | <0.0001% |
| TANNENBAUM RENEE P | director | 20000 0.0257% | $17,262.00 | 2 | 0 | <0.0001% |
| ADAMS THOMAS PHD | director | 18875 0.0243% | $16,291.01 | 1 | 2 | +599.3% |
| Armitage James O | director | 13000 0.0167% | $11,220.30 | 3 | 0 | +185.01% |
| BRANCACCIO JOHN P | director | 12260 0.0158% | $10,581.61 | 3 | 0 | +279.19% |
| Kelemen Vicki | Exec. VP and COO | 6053 0.0078% | $5,224.34 | 1 | 1 | <0.0001% |
| WELCH WILLIAM J | CEO | 4750 0.0061% | $4,099.73 | 1 | 0 | <0.0001% |
$5,831,763 | 118 | -33.78% | $66.68M | |
$9,405,928 | 107 | 12.61% | $74.85M | |
$17,525,882 | 60 | 5.22% | $64.7M | |
$103,288,323 | 51 | 4.78% | $56.52M | |
Cardiff Oncology, Inc. (CRDF) | $19,705,388 | 47 | 86.26% | $67.15M |
| Increased Positions | 43 | +30.5% | 4M | +16.27% |
| Decreased Positions | 53 | -37.59% | 2M | -7.21% |
| New Positions | 17 | New | 2M | New |
| Sold Out Positions | 20 | Sold Out | 652,553 | Sold Out |
| Total Postitions | 131 | -7.09% | 25M | +9.06% |
| Blackrock, Inc. | $10,602.00 | 5.95% | 3.99M | +49,040 | +1.25% | 2025-09-30 |
| Vanguard Group Inc | $9,547.00 | 5.36% | 3.59M | -139,401 | -3.74% | 2025-09-30 |
| Laurion Capital Management Lp | $6,559.00 | 3.68% | 2.47M | +668,590 | +37.2% | 2025-09-30 |
| Blair William & Co/Il | $5,888.00 | 3.3% | 2.21M | -310,512 | -12.3% | 2025-09-30 |
| Acorn Capital Advisors, Llc | $5,219.00 | 2.93% | 1.96M | +553,317 | +39.28% | 2025-09-30 |
| Geode Capital Management, Llc | $4,105.00 | 2.3% | 1.54M | +44,482 | +2.97% | 2025-09-30 |
| State Street Corp | $3,049.00 | 1.71% | 1.15M | +19,833 | +1.76% | 2025-09-30 |
| Flputnam Investment Management Co | $1,589.00 | 0.89% | 597,233 | +543,370 | +1,008.8% | 2025-09-30 |
| Northern Trust Corp | $1,383.00 | 0.78% | 519,752 | -204,699 | -28.26% | 2025-09-30 |
| Goldman Sachs Group Inc | $1,210.00 | 0.68% | 454,726 | +378,392 | +495.71% | 2025-09-30 |